Understanding Physical Activity and Cancer Survival
This study is looking at how physical activity (PA) levels in people with advanced cancer, including head and neck, colorectal, and pancreatic cancers, relate to their overall health and how long they live. Researchers want to see if the activity levels measured by devices like accelerometers match what healthcare providers (HCPs) assess as a patient's ECOG Performance Status (a scale that measures how well a person can perform daily activities). You might participate in walking or strengthening programs and use devices like accelerometers, blood pressure monitors, and smartphones to track your health. The goal is to improve how we understand and use physical activity information for advanced cancer patients. The study is currently unclear on its recruitment status.
- Study design
- This interventional study plans to enroll 590 participants. It is structured with different arms, where participants use various health monitoring devices.
- What's involved
- You would use devices like accelerometers, blood pressure monitors, and smartphones for 5 consecutive days, and then again for another 5 days after a two-week break. You might also participate in a walking or strengthening program.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for up to 7 months after their baseline assessment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Susan K Peterson · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Study completion (defined as completing the final assessment)Up to 7 months after baseline
- Physical Activity (PA) AssessmentUp to 7 days
PA will be measured by two different devices, (1) a consumer-grade wrist-worn device that collects continuous PA data (Fitbit), and (2) a research-grade, hip-worn accelerometer (Actigraph)
- ECOG Performance StatusUp to 2 weeks
Eastern Cooperation Oncology Group (ECOG) is a 6-point performance status scale used to assess performance using PA as a key indicator (e.g., 0 = fully active, 2 = up and about more than 50% of walking hours, 5 = dead) Performance status will be assessed per usual clinical practice and will be recorded in the medical record.